repair-maintenance Altimmune, Inc. (ALT) Discusses Topline 48-Week Results From IMPACT Phase IIb Trial of Pemvidutide in MASH – Slideshow 12월 20, 2025 📋 Altimmune, Inc. (ALT) Discusses Topline 48-Week Results From...Read More